VitriVax logo

VitriVax Funding & Investors

Boulder, CO

VitriVax is a biotech startup that develops a vaccine formulation platform. VitriVax's proprietary technology, created at the University of Colorado with the support of over $5M from NIH, NSF and the State of Colorado, and most recently, $2.2M from the Bill and Melinda Gates Foundation, makes human and animal vaccines more effective, more affordable, and more accessible globally. VitriVax is headquartered in Boulder, Colorado.

vitrivaxbio.com

Total Amount Raised: $8,600,000

VitriVax Funding Rounds

  • Grant

    $3,600,000

    Grant Investors

    Bill & Melinda Gates Foundation
  • Grant

    $5,000,000

    Grant Investors

    Bill & Melinda Gates Foundation
Funding info provided by Diffbot.